Is Your Favorite Pharmacy About To Go Belly Up?
Walgreens Boots Alliance stands at a critical juncture in the company’s 170-year history with revenues of $147 billion but a market capitalization of just $7 billion.
A heavily burdened balance sheet has been the prime culprit of the stock’s downfall but, under new CEO Tim Wentworth, management is undertaking an ambitious realignment aimed at stabilizing the core pharmacy business while taking the chop to some of its healthcare investments. » Read more about: Is Your Favorite Pharmacy About To Go Belly Up? »
Read More
Want an 8% Dividend Yield? You Need to See This REIT
When you find a stock that pays an 8% dividend yield, you have to question its sustainability.
Medical Properties Trust (MPW) is one such stock, and while it may seem like a potential dividend trap, this healthcare REIT’s recent earnings were solid.
» Read more about: Want an 8% Dividend Yield? You Need to See This REIT »
Read More
Insurance + AI = Massive Upside?
There hasn’t been a start to the year as bad as this one since 1970. By June, the market had officially slid into bear market territory.
But among the laundry list of lemons, one compelling buy candidate now is Lemonade (LMND), a growth stock that fell out of Wall Street’s favor and collapsed from all-time highs of $81.68 per share to a recent 52-week low of $15.99 per share.
» Read more about: Insurance + AI = Massive Upside? »
Read More
Terrifying Prediction From Palantir Boss
Is your portfolio built to withstand terrible times? If not, the future could be bleak. At least, that is the takeaway after listening to Palantir boss, Alex Karp.
Karp spoke with early Palantir investor, Stanley Druckenmiller and shared perhaps the bleakest outlook on the future of any prognosticator in recent times. Indeed, if Karp is right,
» Read more about: Terrifying Prediction From Palantir Boss »
Read More
37.9% Upside In Overlooked AI Stock
Some concerns have arisen in recent months that the fuel behind the AI fire is starting to wane. The flagship AI stock, NVIDIA, gained 156% through the first six months of the year, but Nvidia shares only gained 18.8% since the midpoint of 2024. While that is still substantial growth, it reflects investors’ concerns about AI’s ability to generate substantial revenue.
» Read more about: 37.9% Upside In Overlooked AI Stock »
Read MoreThe Burst
Why This Buffett Stock Is a Forever Buy
Among Warren Buffett’s favorite investments is Coca-Cola, a Dividend King that has raised its dividend annually for a remarkable 62 consecutive years. This track record puts Coca-Cola in the elite club of dividend-paying stocks that have increased their dividends annually for at least 50 years.
Such consistent dividend hikes not only help investors to combat inflation but also substantially compound their returns.
» Read more about: Why This Buffett Stock Is a Forever Buy »
Read MoreThe Spotlight
Forgot Zoom? That’s Why It’s Time To Buy
During COVID, you couldn’t tune into financial news networks without hearing about Zoom. The company and its stock was the poster-child for thriving businesses during lockdowns. On January 3, 2020, ZM share price closed at $67.28 per share. By October 16, just 10 months later, it had soared to $550 per share, an all-time high that still stands today.
» Read more about: Forgot Zoom? That’s Why It’s Time To Buy »
Read MoreThe Daily
3 ETFs Warren Buffett Is Quietly Keeping in His Secret Portfolio
© frank_peters / Shutterstock.com
The name Warren Buffett has become interchangeable with Berkshire Hathaway (NYSE:BRK-B). But in a separate portfolio, he holds ETFs like the iShares Core MSCI EA (BATS:IEFA),
» Read more about: 3 ETFs Warren Buffett Is Quietly Keeping in His Secret Portfolio »